9 Result(s)

Article

Clinical features and outcomes in primary nervous system histiocytic neoplasms

Nabeela Nathoo, Joon H. Uhm, Alyx B. Porter, Julie Hammack… in Blood Cancer Journal (2024)

Article

Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

Filippo Pinto e Vairo, Jennifer L. Kemppainen… in Journal of Translational Medicine (2024)

Article

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome

Jennifer A. McCombe, Bryan T. Klassen, Eoin P. Flanagan… in Journal of Neurology (2023)

Article

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion of RD has an und...

Filippo Pinto e Vairo, Jennifer L. Kemppainen… in Journal of Translational Medicine (2023)

Article

Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis

Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum… in Scientific Reports (2023)

Article

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis

Optic neuritis (ON) is a frequent presentation at onset of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). ...

Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum… in Scientific Reports (2022)

Article

Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD

Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders (AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)–IgG-associated disease (MOGAD) are inflammatory demyelina...

Vyanka Redenbaugh, Eoin P. Flanagan in Neurotherapeutics (2022)

Article

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We histopathologically analyzed 2 autopsie...

Romana Höftberger, Yong Guo, Eoin P. Flanagan… in Acta Neuropathologica (2020)

Article

Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue

Several studies in the United Kingdom and Asia have suggested that medical students and residents have particular difficulty in diagnosing and managing patients with neurological problems. Little recent inform...

Andrey V Zinchuk, Eoin P Flanagan, Niall J Tubridy, Wendy A Miller… in BMC Medical Education (2010)